Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SINGS, Heather L")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

Prophylactic HPV vaccines : New interventions for cancer controlBARR, Eliav; SINGS, Heather L.Vaccine. 2008, Vol 26, Num 49, pp 6244-6257, issn 0264-410X, 14 p.Article

The Efficacy and Safety of the Quadrivalent Human Papillomavirus 6/11/16/18 Vaccine GardasilHAUPT, Richard M; SINGS, Heather L.Journal of adolescent health. 2011, Vol 49, Num 5, pp 467-475, issn 1054-139X, 9 p.Article

Dihydrocarbazole alkaloids from Aspergillus tubingensisSINGS, Heather L; HARRIS, Guy H; DOMBROWSKI, Anne W et al.Journal of natural products (Print). 2001, Vol 64, Num 6, pp 836-838, issn 0163-3864Article

Incidence and Risk Factors for Genital Chlamydia trachomatis Infection : A 4-Year Prospective Cohort StudySKJELDESTAD, Finn Egil; MARSICO, Mark A; SINGS, Heather L et al.Sexually transmitted diseases. 2009, Vol 36, Num 5, pp 273-279, issn 0148-5717, 7 p.Article

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 YearsBROWN, Darron R; KJAER, Susanne K; AULT, Kevin A et al.The Journal of infectious diseases. 2009, Vol 199, Num 7, pp 926-935, issn 0022-1899, 10 p.Article

Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women : study design and cohort characteristicsSKJELDESTAD, Finn Egil; MEHTA, Vinay; ESSER, Mark T et al.Acta obstetricia et gynecologica Scandinavica. 2008, Vol 87, Num 1, pp 81-88, issn 0001-6349, 8 p.Article

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccineAULT, Kevin A; JOURA, Elmar A; TANG, Grace W. K et al.International journal of cancer (Print). 2011, Vol 128, Num 6, pp 1344-1353, issn 0020-7136, 10 p.Article

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesGARLAND, Suzanne M; HERNANDEZ-AVILA, Mauricio; TADDEO, Frank J et al.The New England journal of medicine. 2007, Vol 356, Num 19, pp 1928-1943, issn 0028-4793, 16 p.Article

Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionHAUPT, Richard M; WHEELER, Cosette M; RADLEY, David R et al.International journal of cancer (Print). 2011, Vol 129, Num 11, pp 2632-2642, issn 0020-7136, 11 p.Article

Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle VaccineBLOCK, Stan L; BROWN, Darron R; HAIPING ZHOU et al.The Pediatric infectious disease journal. 2010, Vol 29, Num 2, pp 95-101, issn 0891-3668, 7 p.Article

Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulatorsLIANGQIN GUO; ZHIXIONG YE; QIANPING PENG et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 11, pp 3242-3247, issn 0960-894X, 6 p.Article

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents : A randomized controlled trialREISINGER, Keith S; BLOCK, San L; ALVAREZ, Frances B et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 3, pp 201-209, issn 0891-3668, 9 p.Article

Human Papillomavirus Infections and Vulvar Disease DevelopmentGARLAND, Suzanne M; INSINGA, Ralph P; SINGS, Heather L et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 6, pp 1777-1784, issn 1055-9965, 8 p.Article

Clinical Trial Experience With Prophylactic Human Papillomavirus 6/11/16/18 Vaccine in Young Black WomenCLARK, Liana R; MYERS, Evan R; GARNER, Elizabeth I. O et al.Journal of adolescent health. 2013, Vol 52, Num 3, pp 322-329, issn 1054-139X, 8 p.Article

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young WomenMUNOZ, Nubia; KJAER, Susanne K; GARCIA, Patricia J et al.Journal of the National Cancer Institute. 2010, Vol 102, Num 5, pp 325-339, issn 0027-8874, 15 p.Article

Natural History of Genital Warts : Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) VaccineGARLAND, Suzanne M; STEBEN, Marc; SINGS, Heather L et al.The Journal of infectious diseases. 2009, Vol 199, Num 6, pp 805-814, issn 0022-1899, 10 p.Article

Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine: A Combined Analysis of Five Randomized Controlled TrialsGARLAND, Suzanne M; AULT, Kevin A; HAIPING ZHOU et al.Obstetrics and gynecology (New York. 1953). 2009, Vol 114, Num 6, pp 1179-1188, issn 0029-7844, 10 p.Article

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6,11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions : a combined analysis of three randomised clinical trialsJOURA, Elmar A; LEODOLTER, Sepp; STEBEN, Marc et al.Lancet (British edition). 2007, Vol 369, Num 9574, pp 1693-1702, issn 0140-6736, 10 p.Article

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasiaLEHTINEN, Matti; AULT, Kevin A; PAAVONEN, Jorma et al.Sexually transmitted infections. 2011, Vol 87, Num 5, pp 372-376, issn 1368-4973, 5 p.Article

Impact of a prophylactic quadrivalent human papillomavirus (types 6,11,16,18) L1 virus-like particle vaccine in a sexually active population of North American womenBARR, Eliav; GAUSE, Christine K; BAUTISTA, Oliver M et al.American journal of obstetrics and gynecology. 2008, Vol 198, Num 3, pp 261-263, issn 0002-9378, 3 p.Article

Longitudinal Evaluation of Interobserver and Intraobserver Agreement of Cervical Intraepithelial Neoplasia Diagnosis Among an Experienced Panel of Gynecologic PathologistsBING CAI; RONNETT, Brigitte M; LIAW, Kai-Li et al.The American journal of surgical pathology. 2007, Vol 31, Num 12, pp 1854-1860, issn 0147-5185, 7 p.Article

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18VILLA, Luisa L; AULT, Kevin A; KURMAN, Robert J et al.Vaccine. 2006, Vol 24, Num 27-28, pp 5571-5583, issn 0264-410X, 13 p.Article

Proximity of First Sexual Intercourse to Menarche and Risk of High-Grade Cervical DiseaseRUIZ, Angela Maria; RUIZ, Jaime Enrique; VELASQUEZ GAVILANES, Andrés et al.The Journal of infectious diseases. 2012, Vol 206, Num 12, pp 1887-1896, issn 0022-1899, 10 p.Article

Boceprevir for Previously Treated Chronic HCV Genotype 1 InfectionBACON, Bruce R; GORDON, Stuart C; BURROUGHS, Margaret et al.The New England journal of medicine. 2011, Vol 364, Num 13, pp 1207-1217, issn 0028-4793, 11 p.Article

The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trialsSTOLER, Mark H; VICHNIN, Michelle D; ALVAREZ, Frances et al.International journal of cancer (Print). 2011, Vol 128, Num 6, pp 1354-1362, issn 0020-7136, 9 p.Article

  • Page / 2